Table 1.

Clinical data of the patient population included in this study.

Patient no.	Gender	Age (y)	BMI (kg/m2)	Time-interval since transplantation (months)	Type of donor	Primary disease	HTA	Plasma creatinine (µmol/L)	GFR (mL/min/1.73 m2)	ASL (mL/min/100 g)
1	M	5	17.72	1	Living	CAKUT	No	73	55.56	136
2	F	18	17.8	13	Cadaveric	CAKUT	No	119	46.25	178
3	F	18	19.04	1	Cadaveric	CAKUT	No	69	66.82	160
4	F	19	25.56	66	Cadaveric	Nephronophthisis	Yes	107	76.46	210
5	M	19	25.4	1	Living	Nephronophthisis	No	144	36.23	85
6	M	29	20.2	83	Cadaveric	Nephrotic syndrome	Yes	108	65.25	249
7	M	16	19.6	4	Cadaveric	Nephronophthisis	Yes	146	77.67	211
8	M	15	28.27	45	Living	CAKUT	Yes	93	59.1	164
9	F	20	20.04	187	Living	Nephronophthisis	Yes	102	50.99	141
10	F	15	21.8	79	Cadaveric	Wilms tumour	No	90	64	109
11	F	9	15.68	82	Living	Congenital nephrotic syndrome	Yes	81	72.85	261
12	F	13	23.32	108	Living	Congenital nephrotic syndrome	No	117	57.09	204
13	M	13	16.55	112	Living	Congenital nephrotic syndrome	Yes	86	80.27	243
14	M	13	22.02	73	Living	Nephronophthisis	Yes	81	58.03	114
15	F	13	37.29	75	Living	Nephronophthisis	Yes	108	32.08	100
16	M	14	18.67	12	Cadaveric	CAKUT	No	68	93.39	303
17	M	19	21.63	161	Living	CAKUT	Yes	171	66.06	233
18	M	21	32.98	109	Cadaveric	CAKUT	Yes	206	41.58	194

M: male; F: female; BMI: body mass index; HTA: hypertension; GFR: glomerular filtration rate; ASL: arterial spin labelling perfusion; CAKUT: congenital anomalies of the kidney and urinary tract.